New for 2019, the tool includes the CDC’s extramural global activities around antibiotic resistance and showcases successes that came after Congress’ investment in the agency’s antibiotic resistance solutions initiative.
The antibiotic resistance investment map includes:
- Global and domestic extramural collaborations to identify and implement innovative solutions to protect people from the threat of antibiotic resistance.
- Over 170 state-reported successes, such as containing rare resistant germs to protect communities and prevent the spread of harmful germs.
- Printable global-, state-, and city-specific fact sheets showing how the CDC invests in activities in that area.
Click here to view the map.
More articles on clinical leadership and infection control:
1 in 4 antibiotic prescriptions are unnecessary, study finds
84% of patients receive antibiotics for infection-like symptoms, survey finds
WHO internal probe targets claims it misspent money for Ebola response
